145 related articles for article (PubMed ID: 9482595)
1. An examination of radiation exposure to clinical staff from patients implanted with 137Cs and 192Ir for the treatment of gynecologic malignancies.
Smith CL; Chu WK; Granville D; Nabity L
Health Phys; 1998 Mar; 74(3):301-8. PubMed ID: 9482595
[TBL] [Abstract][Full Text] [Related]
2. Effect of bedside shielding on air-kerma rates around gynecologic intracavitary brachytherapy patients containing 226Ra or 137Cs.
Papin PJ; Ramsey MJ; LaFontaine RL; LePage RP
Health Phys; 1990 Apr; 58(4):405-10. PubMed ID: 2323922
[TBL] [Abstract][Full Text] [Related]
3. A multiple-site perineal applicator (MUPIT) for treatment of prostatic, anorectal, and gynecologic malignancies.
Martinez A; Cox RS; Edmundson GK
Int J Radiat Oncol Biol Phys; 1984 Feb; 10(2):297-305. PubMed ID: 6706724
[TBL] [Abstract][Full Text] [Related]
4. Radiation exposure rates near brachytherapy patients containing 137Cs sources.
Glasgow GP; Walker S; Williams JD
Health Phys; 1985 Jan; 48(1):97-104. PubMed ID: 3967977
[TBL] [Abstract][Full Text] [Related]
5. Radiation exposure to personnel in departments of gynaecologic oncology in Sweden.
Forsberg B; Spanne P; Hertzman S
Acta Oncol; 1987; 26(2):113-23. PubMed ID: 3606866
[TBL] [Abstract][Full Text] [Related]
6. Outpatient template-guided permanent interstitial brachytherapy using
Feddock J; Aryal P; Steber C; Edwards J; Cheek D; Randall M
Brachytherapy; 2017; 16(2):393-401. PubMed ID: 28139423
[TBL] [Abstract][Full Text] [Related]
7. On the need for massive additional shielding of a catheterization laboratory for the implementation of high dose rate 192Ir intravascular brachytherapy.
Bohan M; Yue N; Nath R
Cardiovasc Radiat Med; 2000; 2(1):39-41. PubMed ID: 11229061
[TBL] [Abstract][Full Text] [Related]
8. Experience with remote afterloading technique in intracavitary therapy.
Leung PM
Int J Radiat Oncol Biol Phys; 1984 Jan; 10(1):157-62. PubMed ID: 6421782
[TBL] [Abstract][Full Text] [Related]
9. Effect of source encapsulation on the energy spectra of 192Ir and 137Cs seed sources.
Thomason C; Mackie TR; Lindstrom MJ
Phys Med Biol; 1991 Apr; 36(4):495-505. PubMed ID: 2047398
[TBL] [Abstract][Full Text] [Related]
10. Computed tomography-planned interstitial brachytherapy for locally advanced gynecologic cancer: Outcomes and dosimetric predictors of urinary toxicity.
Amsbaugh MJ; Bhatt N; Hunter T; Gaskins J; Parker L; Metzinger D; Amsbaugh A; Sowards K; El-Ghamry MN
Brachytherapy; 2016; 15(1):49-56. PubMed ID: 26614237
[TBL] [Abstract][Full Text] [Related]
11. [A comparison between the dose distribution from 192Ir point and line sources in the afterloading therapy of gynecologic neoplasms].
Günther R; Kloetzer KH; Walter W; Kob D
Radiobiol Radiother (Berl); 1989; 30(2):123-30. PubMed ID: 2748802
[TBL] [Abstract][Full Text] [Related]
12. Radiation Exposure and Safety Precautions Following 131Cs Brachytherapy in Patients with Brain Tumors.
Yondorf MZ; Schwartz TH; Boockvar JA; Pannullo S; Stieg P; Sabbas A; Pavese A; Trichter S; Nedialkova L; Parashar B; Nori D; Chao KS; Wernicke AG
Health Phys; 2017 Apr; 112(4):403-408. PubMed ID: 28234701
[TBL] [Abstract][Full Text] [Related]
13. Radial dose distribution of 192Ir and 137Cs seed sources.
Thomason C; Higgins P
Med Phys; 1989; 16(2):254-7. PubMed ID: 2716705
[TBL] [Abstract][Full Text] [Related]
14. Pulsed dose rate (PDR) brachytherapy as salvage treatment of locally advanced or recurrent gynecologic cancer.
Jensen PT; Roed H; Engelholm SA; Rosendal F
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1041-7. PubMed ID: 9869227
[TBL] [Abstract][Full Text] [Related]
15. Comparison of radiation shielding requirements for HDR brachytherapy using 169Yb and 192Ir sources.
Lymperopoulou G; Papagiannis P; Sakelliou L; Georgiou E; Hourdakis CJ; Baltas D
Med Phys; 2006 Jul; 33(7):2541-7. PubMed ID: 16898458
[TBL] [Abstract][Full Text] [Related]
16. Implementation and early clinical results utilizing Cs-131 permanent interstitial implants for gynecologic malignancies.
Wooten CE; Randall M; Edwards J; Aryal P; Luo W; Feddock J
Gynecol Oncol; 2014 May; 133(2):268-73. PubMed ID: 24556059
[TBL] [Abstract][Full Text] [Related]
17. The American College of Radiology and the American Brachytherapy Society practice parameter for the performance of low-dose-rate brachytherapy.
Viswanathan AN; Erickson BA; Ibbott GS; Small W; Eifel PJ
Brachytherapy; 2017; 16(1):68-74. PubMed ID: 28109633
[TBL] [Abstract][Full Text] [Related]
18. Innovations in brachytherapy in gynecologic oncology.
Brady LW; Micaily B; Miyamoto CT; Heilmann HP; Montemaggi P
Cancer; 1995 Nov; 76(10 Suppl):2143-51. PubMed ID: 8635014
[TBL] [Abstract][Full Text] [Related]
19. Comments on "Radial dose distribution of 192Ir and 137Cs seed sources".
Meli JA; Meigooni AS; Nath R
Med Phys; 1989; 16(5):824-5. PubMed ID: 2811765
[No Abstract] [Full Text] [Related]
20. Attenuation of intracavitary applicators in 192Ir-HDR brachytherapy.
Ye SJ; Brezovich IA; Shen S; Duan J; Popple RA; Pareek PN
Med Phys; 2004 Jul; 31(7):2097-106. PubMed ID: 15305463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
